Wells Fargo’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-25,000
| Closed | -$67K | – | 7097 |
|
|
2019
Q3 | $67K | Hold |
25,000
| – | – | ﹤0.01% | 5476 |
|
|
2019
Q2 | $33K | Buy |
+25,000
| New | +$2.37M | ﹤0.01% | 5677 |
|
|
2018
Q4 | – | Sell |
-19,300
| Closed | -$12K | – | 6898 |
|
|
2018
Q3 | $12K | Sell |
19,300
-3,200
| -14% | -$283K | ﹤0.01% | 5961 |
|
|
2018
Q2 | $20K | Sell |
22,500
-6,800
| -23% | -$565K | ﹤0.01% | 5821 |
|
|
2018
Q1 | $20K | Sell |
29,300
-700
| -2% | -$67.2K | ﹤0.01% | 5815 |
|
|
2017
Q4 | $20K | Sell |
30,000
-50,700
| -63% | -$5.72M | ﹤0.01% | 5797 |
|
|
2017
Q3 | $1.89M | Buy |
80,700
+50,700
| +169% | +$6.91M | ﹤0.01% | 3360 |
|
|
2017
Q2 | $709K | Hold |
30,000
| – | – | ﹤0.01% | 3983 |
|
|
2017
Q1 | $655K | Sell |
30,000
-90,000
| -75% | -$10.8M | ﹤0.01% | 4066 |
|
|
2016
Q4 | $2.68M | Sell |
120,000
-4,800
| -4% | -$535K | ﹤0.01% | 2916 |
|
|
2016
Q3 | $1.46M | Buy |
124,800
+88,800
| +247% | +$9.61M | ﹤0.01% | 3207 |
|
|
2016
Q2 | $353K | Buy |
+36,000
| New | +$3.72M | ﹤0.01% | 4105 |
|
|
2016
Q1 | – | Sell |
-18,000
| Closed | -$1K | – | 6790 |
|
|
2015
Q4 | $1K | Buy |
18,000
+8,400
| +88% | +$972K | ﹤0.01% | 6173 |
|
|
2015
Q3 | $2K | Buy |
+9,600
| New | +$1.19M | ﹤0.01% | 6034 |
|
|
2015
Q1 | – | Sell |
-32,000
| Closed | -$190K | – | 6709 |
|
|
2014
Q4 | $190K | Buy |
+32,000
| New | +$3.37M | ﹤0.01% | 4457 |
|
|
2014
Q1 | – | Sell |
-7,000
| Closed | -$7K | – | 6426 |
|
|
2013
Q4 | $7K | Sell |
7,000
-200
| -3% | -$15.8K | ﹤0.01% | 5297 |
|
|
2013
Q3 | $14K | Buy |
+7,200
| New | +$505K | ﹤0.01% | 5062 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Wells Fargo's CELG Position: Q4 2019 in Review
Wells Fargo sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,143,828 shares — an estimated $213M sold.
Wells Fargo first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.08B in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Wells Fargo reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Wells Fargo sold 2,143,828 Celgene Corp shares in Q4 2019, an estimated $213M.
- Wells Fargo first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Wells Fargo's Celgene Corp position peaked at $1.08B in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Wells Fargo's 13F filing for Q4 2019, filed 14 Feb 2020.